Jackman Stephan 4
4 · Alzamend Neuro, Inc. · Filed May 2, 2023
Insider Transaction Report
Form 4
Jackman Stephan
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2023-04-28$0.54/sh+37,000$19,999→ 45,500 total
Footnotes (1)
- [F1]The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.5405. The range of purchase prices on the transaction date was $0.5398 to $0.5499 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.